Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration

BACKGROUND/AIMS: To study the initial characteristics and response to intravitreal ranibizumab (IVR) treatment of age-related macular degeneration (AMD). METHODS: We reviewed the clinical records of 141 eyes in 141 AMD patients who received monthly IVR for 3 months and thereafter pro re nata (PRN) i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Suzuki, Misa, Nagai, Norihiro, Izumi-Nagai, Kanako, Shinoda, Hajime, Koto, Takashi, Uchida, Atsuro, Mochimaru, Hiroshi, Yuki, Kenya, Sasaki, Mariko, Tsubota, Kazuo, Ozawa, Yoko
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2014
Matèries:
Clinical Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145467/
https://ncbi.nlm.nih.gov/pubmed/24711658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2013-304670
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars